ID   K562-FLUD
AC   CVCL_Z734
SY   K/flud; K/fluda
DR   Wikidata; Q54899383
RX   PubMed=10500836;
CC   Selected for resistance to: ChEBI; CHEBI:63599; Fludarabine phosphate.
CC   Sequence variation: BCR-ABL1 gene fusion (from parent cell line).
CC   Sequence variation: Homozygous for TP53 p.Gln136fs*13 (c.406_407insC) (from parent cell line).
CC   Derived from sampling site: Pleural effusion.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 12-03-20; Version: 9
RX   PubMed=10500836; DOI=10.1007/978-1-4615-4811-9_63;
RA   Dumontet C., Bauchu E.C., Fabianowska K., Lepoivre M.,
RA   Wyczechowska D., Bodin F., Rolland M.O.;
RT   "Common resistance mechanisms to nucleoside analogues in variants of
RT   the human erythroleukemic line K562.";
RL   Adv. Exp. Med. Biol. 457:571-577(1999).